Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review

References

• HvistendahlMChina. World’s biggest health care system goes under the knifeScience2013339611950550723371991
   PubMed Web of Science ®Google Scholar
• PhillipsMRZhangJShiQPrevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001–2005: an epidemiological surveyLancet200937396802041205319524780
   PubMed Web of Science ®Google Scholar
• RobinsonDWoernerMGAlvirJMPredictors of relapse following response from a first episode of schizophrenia or schizoaffective disorderArch Gen Psychiatry199956324124710078501
   PubMed Web of Science ®Google Scholar
• MontgomeryWLiuLStenslandMDXueHBTreuerTAscher-SvanumHThe personal, societal, and economic burden of schizophrenia in the People’s Republic of China: implications for antipsychotic therapyClinicoecon Outcomes Res2013540741823983478
   PubMedGoogle Scholar
• LeuchtSCiprianiASpineliLComparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysisLancet2013382989695196223810019
   PubMed Web of Science ®Google Scholar
• PhillipsMRCharacteristics, experience, and treatment of schizophrenia in ChinaDialogues Clin Neurosci20013210911922033637
   PubMedGoogle Scholar
• ItoHOkumuraYHiguchiTTanCHShinfukuNInternational variation in antipsychotic prescribing for schizophrenia: pooled results from the research on East Asia psychotropic prescription (REAP) studiesOpen J Psychiatr20122340346
   Google Scholar
• XiangYTWengYZLeungCMTangWKUngvariGSClinical and social determinants of antipsychotic polypharmacy for Chinese patients with schizophreniaPharmacopsychiatry2007402475217447172
   PubMed Web of Science ®Google Scholar
• AggarwalNKTaoHXuKStefanovicsEZheningLRosenheckRAComparing the PANSS in Chinese and American inpatients: cross-cultural psychiatric analyses of instrument translation and implementationSchizophr Res20111322–314615221885258
   PubMed Web of Science ®Google Scholar
• Lilly Suzhou Pharmaceutical Co. LtdZyprexa Approved Product Information (Chinese version) Data on fileAccessed October 17, 2013 English translation
   Google Scholar
• PangNWangTAnalysis for the antipsychotics usage during 2008 to 2009J Mod Med Health201228913811382
   Google Scholar
• YangP[The usage of antipsychotics]Chinese and Foreign Medical Research201311185960 Chinese
   Google Scholar
• XiangYTKreyenbuhlJDickersonFBUse of first- and second-generation antipsychotic medications in older patients with schizophrenia in Asia (2001–2009)Aust N Z J Psychiatry201246121159116422790175
   PubMed Web of Science ®Google Scholar
• BuckleyPFOlanzapine: a critical review of recent literatureExpert Opin Pharmacother20056122077208916197360
   PubMed Web of Science ®Google Scholar
• BhanaNPerryCMOlanzapine: a review of its use in the treatment of bipolar I disorderCNS Drugs2001151187190411700151
   PubMed Web of Science ®Google Scholar
• FultonBGoaKLOlanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychosesDrugs19975322812989028746
   PubMed Web of Science ®Google Scholar
• FungICChinese journals: a guide for epidemiologistsEmerg Themes Epidemiol200852018826604
   PubMedGoogle Scholar
• WangMYZhouZXFangHLLiuXLThe bibliometric characteristics of Chinese medical core journalsSerials Review2011371913
   Web of Science ®Google Scholar
• WangCHLiYYangJA randomized controlled trial of olanzapine improving memory deficits in Han Chinese patients with first-episode schizophreniaSchizophr Res20131441–312913523352776
   PubMed Web of Science ®Google Scholar
• ZhuQYPiJF[The effect of olanzapine on the quality of life of patients with schizophrenia]Herald of Medicine2012313334336 Chinese
   Google Scholar
• XieQFengSHZengHL[Efficacies of paliperidone extended-release tablets and olanzapine for treating schizophrenia in children and adolescents]Chinese Journal of New Drugs2012211619161919 Chinese
   Google Scholar
• FangMSZhaoJPGuoXF[Maintenance treatment effectiveness of seven antipsychotic drugs in schizophrenic patients: a 1-year follow-up study]Chinese Journal of Psychiatry200942116 Chinese
   Google Scholar
• GuoXZhaiJWeiQNeurocognitive effects of first- and second-generation antipsychotic drugs in early-stage schizophrenia: a naturalistic 12-month follow-up studyNeurosci Lett2011503214114621888948
   PubMed Web of Science ®Google Scholar
• GuoXFangMZhaiJEffectiveness of maintenance treatments with atypical and typical antipsychotics in stable schizophrenia with early stage: 1-year naturalistic studyPsychopharmacology (Berl)2011216447548421369751
   PubMed Web of Science ®Google Scholar
• GuoXZhangZZhaiJEffects of antipsychotic medications on quality of life and psychosocial functioning in patients with early-stage schizophrenia: 1-year follow-up naturalistic studyCompr Psychiatry20125371006101222516246
   PubMed Web of Science ®Google Scholar
• YenCFChengCPHuangCFYenJYKoCHChenCSQuality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remissionBipolar Disord200810561762418657246
   PubMed Web of Science ®Google Scholar
• FangMLiLZhaoJ[Effect of antipsychotic drugs on life quality of schizophrenic patients: one year follow-up study]Zhong Nan Da Xue Xue Bao Yi Xue Ban2009349850855 Chinese19779255
   PubMedGoogle Scholar
• KuoCJYangSYLiaoYTSecond-generation antipsychotic medications and risk of pneumonia in schizophreniaSchizophr Bull201339364865722282455
   PubMed Web of Science ®Google Scholar
• LuZHuJChenCKEffectiveness and safety of olanzapine in the treatment of schizophrenia among Asian patients switching from conventional antipsychoticsProg Neuropsychopharmacol Biol Psychiatry2007311324016843580
   PubMed Web of Science ®Google Scholar
• TreuerTHoffmannVPChenAKFactors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: results from a six-month prospective, multinational, observational studyWorld J Biol Psychiatry2009104 Pt 372974019606406
   PubMed Web of Science ®Google Scholar
• YangSYKao YangYHChongMYYangYHChangWHLaiCSRisk of extrapyramidal syndrome in schizophrenic patients treated with antipsychotics: a population-based studyClin Pharmacol Ther200781458659417235331
   PubMed Web of Science ®Google Scholar
• JianWYMiaoGD[The efficacy and safety of atypical antipsychotic drugs combined with sodium valproate in the treatment of bipolar mania]Guangdong Medical Journal2013344641616 Chinese
   Google Scholar
• YangSYLiaoYTLiuHCChenWJChenCCKuoCJAntipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control studyJ Clin Psychiatry2013741e79e8623419234
   PubMed Web of Science ®Google Scholar
• KaySRFiszbeinAOplerLAThe positive and negative syndrome scale (PANSS) for schizophreniaSchizophr Bull19871322612763616518
   PubMed Web of Science ®Google Scholar
• ChenJXWuSYLinR[The efficacy and impacts on glucose and lipid metabolism of ziprasidone and olanzapine in the treatment of elder patients with schizophrenia]Guangdong Medical Journal201233710061008 Chinese
   Google Scholar
• ChenQLiuXLChenYZ[Research on efficacy and safety of olanzapine and ziprasidone in the treatment of schizophrenia]Chinese Journal of Hospital Pharmacy2008282118561858 Chinese
   Google Scholar
• ChenXH[The efficacy of domestic and imported olanzapine in the treatment of schizophrenia and the impacts on glucose and lipid metabolism]Guangdong Medical Journal2010311317361738 Chinese
   Google Scholar
• LiYMZhaoJPOuJJWuRREfficacy and tolerability of ziprasidone vs olanzapine in naive first-episode schizophrenia: a 6-week, randomized, open-label, flexible-dose studyPharmacopsychiatry201245517718122290206
   PubMed Web of Science ®Google Scholar
• TanHWangJM[Controlled clinical trial of domestic olanzapine in the treatment of schizophrenia]Chongqing Medical Journal2009387787788 Chinese
   Google Scholar
• WangXFCuiGMMaJ[The efficacy observation of aripiprazole in the treatment of 48 patients with first-episode schizophrenia]Shandong Medical Journal201050315758 Chinese
   Google Scholar
• YangLHWeiKLSuSY[Clinical efficacy and safety of olanzapine and risperidone in the treatment of first episode schizophrenia]Chinese Journal of Clinical Pharmacology2010269647649 Chinese
   Google Scholar
• YuLLWangXYJinGX[The effects of anti-schizophrenia on serum level of estrogen in male patients with schizophrenia]Chinese Journal of Nervous and Mental Diseases20123812742746 Chinese
   Google Scholar
• ZhuQYPiJF[A comparative study of paliperidone and olanzapine in the treatment of treatment-refractory schizophrenia]Chinese Journal of New Drugs2012216666669 Chinese
   Google Scholar
• LiHJWuAGZhaoHY[The correlation analysis between the efficacy of olanzapine in the treatment of schizophrenia and the blood concentration]Chinese Journal of Nervous and Mental Diseases2003295363365 Chinese
   Google Scholar
• LiuYPLiuEYLanXE[Controlled study of quetiapine and olanzapine combined with sodium valproate in the treatment of female patients with acute manic episode]J Pract Med2009251123125 Chinese
   Google Scholar
• NiufanGTohenMQiuqingAOlanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trialJ Affect Disord20081051–310110817531327
   PubMed Web of Science ®Google Scholar
• TohenMCalabreseJRSachsGSRandomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapineAm J Psychiatry2006163224725616449478
   PubMed Web of Science ®Google Scholar
• YangPDLiJChenDC[A random and controlled trial for evaluating the efficacy and safety of olanzapine and lithium in the treatment of bipolar or mixed type mania]Chinese Journal of New Drugs20081716770 Chinese
   Google Scholar
• BechPRafaelsenOJKrampPBolwigTGThe Mania Rating Scale: scale construction and inter-observer agreementNeuropharmacology1978176430431673161
   PubMed Web of Science ®Google Scholar
• OverallJEGorhamDRThe Brief Psychiatric Rating ScalePsychol Rep196210799812
   Web of Science ®Google Scholar
• MontgomerySAAsbergMA new depression scale designed to be sensitive to changeBr J Psychiatry1979134382389444788
   PubMed Web of Science ®Google Scholar
• YoungRCBiggsJTZieglerVEMeyerDAA rating scale for mania: reliability, validity and sensitivityBr J Psychiatry1978133429435728692
   PubMed Web of Science ®Google Scholar
• TohenMMcDonnellDPCaseMRandomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depressionBr J Psychiatry2012201537638222918966
   PubMed Web of Science ®Google Scholar
• ShenTLiWJ[The efficacy analysis of small-dose olanzpine in treatment of 12 patients with schizophrenia]Shanghai Archives of Psychiatry20001214849 Chinese
   Google Scholar
• ShuLLiuPZhouM[Olanzapine in the treatment of schizophrenia: an open trial clinical study]Chinese Journal of Psychiatry1999324223225 Chinese
   Google Scholar
• WangYCaiLWZhangHX[The efficacy and adverse effects of haloperidol and olanzapine: a randomized controlled study]Chinese Journal of Nervous and Mental Diseases2012384217221 Chinese
   Google Scholar
• YangXNMeiQY[A comparison of olanzapine and risperidone in the treatment of first-episode schizophrenia]Shanghai Archives of Psychiatry2003156338340 Chinese
   Google Scholar
• ZhengHBDengHHZhouL[Open-label trial of olanzapine in the maintenance treatment of 23 patients with schizophrenia]Shanghai Archives of Psychiatry20001214344 Chinese
   Google Scholar
• ChangFWWangCHZhaoZ[A comparison of clinical efficacy between olanzapine and chlorpromazine in the treatment of positive symptoms of schizophrenia]Chinese Journal of New Drugs and Clinical Remedies2003226357359 Chinese
   Google Scholar
• ChenJJChanHYChenCHGauSSHwuHGRisperidone and olanzapine versus another first generation antipsychotic in patients with schizophrenia inadequately responsive to first generation antipsychoticsPharmacopsychiatry2012452647122086749
   PubMed Web of Science ®Google Scholar
• DuNQ[The analysis for comparison of efficacy and safety of ziprasidone and olanzapine in treatment of early schizophrenia]Chongqing Medical Journal2012412829382939 Chinese
   Google Scholar
• GaoGLChenL[The effectiveness of olanzapine in the treatment of first episode schizophrenia]Shanghai Archives of Psychiatry20031513334 Chinese
   Google Scholar
• GuoJHWengYZFangZ[Open-label trial of olanzapine in the treatment of 33 patients with schizophrenia]Shanghai Archives of Psychiatry20001214648 Chinese
   Google Scholar
• MaQLiLXLianHT[A controlled comparison study on paliperidone extended-release tablets and olanzapine in the treatment of schizophrenia]Chinese Journal of New Drugs2012212226582661 Chinese
   Google Scholar
• ZhangHYLiHFGangW[The efficacy and safety of flexible dose of paliperidone extended-release tablets in the treatment of acute schizophrenia: a randomized, double blind olanzapine-controlled study]Chinese Journal of Psychiatry2009423153157 Chinese
   Google Scholar
• LeeELeungCMWongEAtypical antipsychotics and weight gain in Chinese patients: a comparison of olanzapine and risperidoneJ Clin Psychiatry200465686486615291666
   PubMed Web of Science ®Google Scholar
• LiangY[A clinical comparative study on paliperidone ER in treating acute phase schizophrenia patients]Chinese Journal of New Drugs2011202424422445 Chinese
   Google Scholar
• CaoGXXieGJ[Observation of efficacy and safety of paliperidone sustained release tablets and domestic olanzapine in treatment of schizophrenia]Chongqing Medical Journal2011401716951696 Chinese
   Google Scholar
• AngQTangJZhaoJP[Factors associated with weight gain during six-month olanzapine therapy]Chinese Journal of Psychiatry201144316 Chinese
   Google Scholar
• ChanHYChangCJChiangSCA randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonismJ Psychopharmacol2010241919818801830
   PubMed Web of Science ®Google Scholar
• ChanHYChiangSCChangCJA randomized controlled trial of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced tardive dyskinesiaJ Clin Psychiatry20107191226123320441726
   PubMed Web of Science ®Google Scholar
• ChenVCWangTNLuMLWeight gain and ghrelin level after olanzapine monotherapyProg Neuropsychopharmacol Biol Psychiatry201135263263521256176
   PubMed Web of Science ®Google Scholar
• HuSYaoMPetersonBSA randomized, 12-week study of the effects of extended-release paliperidone (paliperidone ER) and olanzapine on metabolic profile, weight, insulin resistance, and beta-cell function in schizophrenic patientsPsychopharmacol (Berl)20132301313
   Web of Science ®Google Scholar
• LeeELeungCMAtypical antipsychotics and metabolic outcomes in Chinese patients: a comparison of olanzapine and risperidoneJ Clin Psychopharmacol200828670770919011445
   PubMed Web of Science ®Google Scholar
• OuJJXuYChenHHComparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophreniaPsychopharmacol (Berl)20132253627635
   PubMed Web of Science ®Google Scholar
• PrattNAndersenMBergmanUMulti-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia studyPharmacoepidemiol Drug Saf201322991592423696036
   PubMed Web of Science ®Google Scholar
• SuKPWuPLParianteCMA crossover study on lipid and weight changes associated with olanzapine and risperidonePsychopharmacol (Berl)20051833383386
   Web of Science ®Google Scholar
• WuRRZhaoJPLiuZNEffects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophreniaPsychopharmacol (Berl)20061864572578
   Web of Science ®Google Scholar
• WuRRZhaoJPZhaiJGGuoXFGuoWBSex difference in effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophreniaJ Clin Psychopharmacol200727437437917632222
   PubMed Web of Science ®Google Scholar
• DongHXMeiHB[The comparison of quetiapine with olanzapine in the treatment of aged patients with schizophrenia]Herald of Medicine2012312184185 Chinese
   Google Scholar
• SathirakulKChanCTengLBergstromRFYeoKPWiseSDOlanzapine pharmacokinetics are similar in Chinese and Caucasian subjectsBr J Clin Pharmacol200356218418712895191
   PubMed Web of Science ®Google Scholar
• DossenbachMRFolnegovic-SmalcVHotujacLDouble-blind, randomized comparison of olanzapine versus fluphenazine in the long-term treatment of schizophreniaProg Neuropsychopharmacol Biol Psychiatry200428231131814751428
   PubMed Web of Science ®Google Scholar
• FleischhackerWWMcQuadeRDMarcusRNArchibaldDSwaninkRCarsonWHA double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophreniaBiol Psychiatry200965651051718986646
   PubMed Web of Science ®Google Scholar
• GrootensKPvan VeelenNMPeuskensJZiprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trialSchizophr Bull201137235236119542525
   PubMed Web of Science ®Google Scholar
• LublinHHaugHJKoponenHSigmundssonTKolbSAZiprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trialWorld J Biol Psychiatry2009104 Pt 371071818803070
   PubMed Web of Science ®Google Scholar
• SanLArranzBPerezVOne-year, randomized, open trial comparing olanzapine, quetiapine, risperidone and ziprasidone effectiveness in antipsychotic-naive patients with a first-episode psychosisPsychiatry Res20122002–369370122954905
   PubMed Web of Science ®Google Scholar
• TollefsonGDBeasleyCMJrTranPVOlanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trialAm J Psychiatry199715444574659090331
   PubMed Web of Science ®Google Scholar
• VickersAGoyalNHarlandRReesRDo certain countries produce only positive results? A systematic review of controlled trialsControl Clin Trials19981921591669551280
   PubMedGoogle Scholar
• KomossaKRummel-KlugeCHungerHOlanzapine versus other atypical antipsychotics for schizophreniaCochrane Database Syst Rev20103CD00665420238348
   PubMed Web of Science ®Google Scholar
• BreierABergPHThakoreJHOlanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophreniaAm J Psychiatry2005162101879188716199834
   PubMed Web of Science ®Google Scholar
• ConleyRRMahmoudRA randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorderAm J Psychiatry2001158576577411329400
   PubMed Web of Science ®Google Scholar
• GurejeOMilesWKeksNOlanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New ZealandSchizophr Res2003612–330331412729882
   PubMed Web of Science ®Google Scholar
• JesteDVBarakYMadhusoodananSGrossmanFGharabawiGInternational multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophreniaAm J Geriatr Psychiatry200311663864714609804
   PubMed Web of Science ®Google Scholar
• KeefeRSYoungCARockSLOne-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophreniaSchizophr Res200681111516202565
   PubMed Web of Science ®Google Scholar
• HaroJMSuarezDNovickDThree-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies resultsEur Neuropsychopharmacol200717423524417137759
   PubMed Web of Science ®Google Scholar
• LiebermanJAStroupTSMcEvoyJPEffectiveness of antipsychotic drugs in patients with chronic schizophreniaN Engl J Med2005353121209122316172203
   PubMed Web of Science ®Google Scholar
• SangerTMGrundySLGibsonPJNamjoshiMAGreaneyMGTohenMFLong-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase studyJ Clin Psychiatry200162427328111379842
   PubMed Web of Science ®Google Scholar
• TohenMJacobsTGGrundySLEfficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study GroupArch Gen Psychiatry200057984184910986547
   PubMed Web of Science ®Google Scholar
• Ascher-SvanumHFariesDEZhuBErnstFRSwartzMSSwansonJWMedication adherence and long-term functional outcomes in the treatment of schizophrenia in usual careJ Clin Psychiatry200667345346016649833
   PubMed Web of Science ®Google Scholar
• HeXWuJLiuLMontgomeryWYeWXueHBHealth care resource utilization and direct medical costs among patients with schizophrenia in Tianjin, ChinaPoster 13 presented at the Fourth World Congress of Asian PsychiatryAugust 19–22, 2013Bangkok, Thailand
   Google Scholar
• LiuLYeWHeXWuJMontgomeryWXueHBDifferential resource use and costs among inpatients and outpatients with schizophrenia in Tianjin, ChinaPoster 14 presented at the Fourth World Congress of Asian PsychiatryAugust 19–22, 2013Bangkok, Thailand
   Google Scholar
• MontgomeryWKadziolaZYeWXueHBLiuLTreuerTCorrelation between changes in quality of life and symptomatic improvement in Chinese patients switched from typical antipsychotics to olanzapinePoster presented at the Fourth World Congress of Asian PsychiatryAugust 19–22, 2013Bangkok, Thailand
   Google Scholar
• NamjoshiMARajamannarGJacobsTEconomic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania. Results from a randomized controlled trialJ Affect Disord2002691–310911812103458
   PubMed Web of Science ®Google Scholar
• RevickiDAGendusoLAHamiltonSHGanoczyDBeasleyCMJrOlanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trialQual Life Res19998541742610474283
   PubMed Web of Science ®Google Scholar
• Silva de LimaMde Jesus MariJBreierAMaria CostaAPonde de SenaEHotopfMQuality of life in schizophrenia: a multicenter, randomized, naturalistic, controlled trial comparing olanzapine to first-generation antipsychoticsJ Clin Psychiatry200566783183816013897
   PubMed Web of Science ®Google Scholar
• BilderRMGoldmanRSVolavkaJNeurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorderAm J Psychiatry200215961018102812042192
   PubMed Web of Science ®Google Scholar
• KeefeRSSweeneyJAGuHEffects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparisonAm J Psychiatry200716471061107117606658
   PubMed Web of Science ®Google Scholar
• Ayesa-ArriolaRRodriguez-SanchezJMPerez-IglesiasRLong-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidonePsychopharmacol (Berl)20132274615625
   PubMed Web of Science ®Google Scholar
• AllisonDBMentoreJLHeoMAntipsychotic-induced weight gain: a comprehensive research synthesisAm J Psychiatry1999156111686169610553730
   PubMed Web of Science ®Google Scholar
• KantrowitzJTCitromeLOlanzapine: review of safety 2008Expert Opin Drug Saf20087676176918983222
   PubMed Web of Science ®Google Scholar
• Perez-IglesiasRCrespo-FacorroBMartinez-GarciaOWeight gain induced by haloperidol, risperidone and olanzapine after 1 year: findings of a randomized clinical trial in a drug-naive populationSchizophr Res2008991–3132218053689
   PubMed Web of Science ®Google Scholar
• LipkovichICitromeLPerlisREarly predictors of substantial weight gain in bipolar patients treated with olanzapineJ Clin Psychopharmacol200626331632016702898
   PubMed Web of Science ®Google Scholar
• CitromeLHoltRIWalkerDJHoffmannVPWeight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorderClin Drug Investig2011317455482
   PubMed Web of Science ®Google Scholar
• CONSORTThe CONSORT statement Available from: http://www.consort-statement.org/consort-statement/Accessed August 20, 2013
   Google Scholar
• XuLLiJZhangMAiCWangLChinese authors do need CONSORT: reporting quality assessment for five leading Chinese medical journalsContemp Clin Trials200829572773118579449
   PubMed Web of Science ®Google Scholar
• TreuerTLiuCYSalazarGUse of antidepressants in the treatment of depression in Asia: guidelines, clinical evidence, and experience revisitedAsia Pac Psychiatry20135421923023857712
   PubMed Web of Science ®Google Scholar
• WangCHFengYGWangDH[A double-blind randomized controlled study of olanzapine and clozapine on treatment of schizophrenia]Shanghai Archives of Psychiatry2002143143145 Chinese
   Google Scholar
• WangYCYangCCBaiYMKuoTBHeart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine. 3-month follow-upNeuropsychobiology200857420020518679039
   PubMed Web of Science ®Google Scholar
• ChiuCCChenCHChenBYYuSHLuMLThe time-dependent change of insulin secretion in schizophrenic patients treated with olanzapineProg Neuropsychopharmacol Biol Psychiatry201034686687020394794
   PubMed Web of Science ®Google Scholar
• HuangHHWangYCWuCLTNF-alpha -308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatmentNeurosci Lett2011504327728021967963
   PubMed Web of Science ®Google Scholar
• YangXHHuangJZYanHS[Open-label trial of olanzapine in the treatment of 70 patients with schizophrenia]Shanghai Archives of Psychiatry20021429496 Chinese
   Google Scholar